HPV vaccination initiation after the routine-recommended ages of 11-12 in the United States

Papillomavirus Research
Daniel C BeachlerAimée R Kreimer

Abstract

Since 2006, routine HPV vaccination has been recommended for females aged 11-12 in the US. However not much is known about the extent of and factors associated with HPV vaccination after the ages of 11-12. Provider-verified data on 8,710 females aged 13-17 were analyzed from the 2013 NIS-Teen survey. 2013 data was utilized since it was the first year one can fully evaluate the age at vaccination through age 17 for females who could receive the HPV vaccine at age 11. Among HPV vaccinated females who were 17 in 2013, 47% (95%CI=43%-50%) received their first dose after age 12, and 24% (95%CI=21%-26%) received their first dose after age 14. The HPV vaccine was more likely to be initiated later than the meningococcal and Tdap vaccines (p<0.05), and later HPV vaccine initiation was more common among those having a more highly educated mother and those not receiving a check-up/well visit between the ages of 11 and 12 in adjusted analyses (p-values<0.05). Females initiating the HPV vaccine late were more likely to not receive three doses (RR=1.90, 95%CI=1.76-2.04). HPV vaccination is commonly initiated after the age of 12 in the US, which could limit the vaccine's population-level effectiveness.

References

Mar 23, 2004·American Journal of Epidemiology·Guangyong Zou
Aug 21, 2007·JAMA : the Journal of the American Medical Association·Allan HildesheimUNKNOWN Costa Rican HPV Vaccine Trial Group
Jan 9, 2008·The Journal of Infectious Diseases·Rachel L WinerLaura A Koutsky
Jul 28, 2009·Contraception·Patricia A Cavazos-RehgLaura Jean Bierut
Feb 4, 2011·The New England Journal of Medicine·Anna R GiulianoDalya Guris
Sep 13, 2011·Journal of the National Cancer Institute·Aimée R KreimerUNKNOWN CVT Vaccine Group
Apr 7, 2012·Vaccine·Sharon J M KesselsRebecca L Tooher
Apr 3, 2013·Pediatrics·Lawrence B Finer, Jesse M Philbin
Oct 29, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Robert A BednarczykSaad B Omer
Nov 28, 2013·Vaccine·F Xavier BoschUNKNOWN Authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5,
Dec 18, 2013·Vaccine·F Xavier BoschUNKNOWN authors of the ICO Monograph ‘Comprehensive Control of HPV Infections and Related Diseases’ Vaccine Volume 30, Supplement 5,
Dec 18, 2013·Vaccine·F Xavier BoschUNKNOWN authors of ICO Monograph Comprehensive Control of HPV Infections and Related Diseases Vaccine Volume 30, Supplement 5, 2012
Feb 12, 2015·Journal of Community Health·Mahbubur RahmanAbbey B Berenson

❮ Previous
Next ❯

Citations

Jun 1, 2016·Preventive Medicine·Joseph E TotaEduardo L Franco
Oct 21, 2016·Journal of Lower Genital Tract Disease·Mark Spitzer
Jun 10, 2017·Oral Diseases·C S Miller, R N Greenberg
Mar 28, 2018·The Journal of Infectious Diseases·Eshan U PatelAaron A R Tobian

❮ Previous
Next ❯

Software Mentioned

teen
NIS
STATA

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved